Global Anti-Obesity Therapeutics Market Report 2019, Competitive Landscape, Trends and Opportunities
- MAI3201689
- 128 Pages
- July 2019
- BFSI
The report mainly studies the size, recent trends and development status of the Anti-Obesity Therapeutics market, as well as investment opportunities, government policy, market dynamics (drivers, restraints, opportunities), supply chain and competitive landscape. Technological innovation and advancement will further optimize the performance of the product, making it more widely used in downstream applications. Moreover, Porter's Five Forces Analysis (potential entrants, suppliers, substitutes, buyers, industry competitors) provides crucial information for knowing the Anti-Obesity Therapeutics market.
Major players in the global Anti-Obesity Therapeutics market include:
Vivus
Rhythm Pharmaceuticals
Zafgen
Eisai Company
Pfizer
BoehringerIngelheim GmbH
FlaxoSithKline plc.
Bristol-Myers Squibb
Norgine Pharmaceuticals Ltd.
Alizyme
Shionogi USA
Takeda Pharmaceutical
Novo Nordisk
On the basis of types, the Anti-Obesity Therapeutics market is primarily split into:
Centrally Acting Anti-obesity Drugs
Peripherally Acting Anti-obesity Drugs
On the basis of applications, the market covers:
Hospital Use
Clinic Use
Household
Other
Geographically, the report includes the research on production, consumption, revenue, market share and growth rate, and forecast (2014-2026) of the following regions:
United States
Europe (Germany, UK, France, Italy, Spain, Russia, Poland)
China
Japan
India
Southeast Asia (Malaysia, Singapore, Philippines, Indonesia, Thailand, Vietnam)
Central and South America (Brazil, Mexico, Colombia)
Middle East and Africa (Saudi Arabia, United Arab Emirates, Turkey, Egypt, South Africa, Nigeria)
Other Regions
Chapter 1 provides an overview of Anti-Obesity Therapeutics market, containing global revenue, global production, sales, and CAGR. The forecast and analysis of Anti-Obesity Therapeutics market by type, application, and region are also presented in this chapter.
Chapter 2 is about the market landscape and major players. It provides competitive situation and market concentration status along with the basic information of these players.
Chapter 3 provides a full-scale analysis of major players in Anti-Obesity Therapeutics industry. The basic information, as well as the profiles, applications and specifications of products market performance along with Business Overview are offered.
Chapter 4 gives a worldwide view of Anti-Obesity Therapeutics market. It includes production, market share revenue, price, and the growth rate by type.
Chapter 5 focuses on the application of Anti-Obesity Therapeutics, by analyzing the consumption and its growth rate of each application.
Chapter 6 is about production, consumption, export, and import of Anti-Obesity Therapeutics in each region.
Chapter 7 pays attention to the production, revenue, price and gross margin of Anti-Obesity Therapeutics in markets of different regions. The analysis on production, revenue, price and gross margin of the global market is covered in this part.
Chapter 8 concentrates on manufacturing analysis, including key raw material analysis, cost structure analysis and process analysis, making up a comprehensive analysis of manufacturing cost.
Chapter 9 introduces the industrial chain of Anti-Obesity Therapeutics. Industrial chain analysis, raw material sources and downstream buyers are analyzed in this chapter.
Chapter 10 provides clear insights into market dynamics.
Chapter 11 prospects the whole Anti-Obesity Therapeutics market, including the global production and revenue forecast, regional forecast. It also foresees the Anti-Obesity Therapeutics market by type and application.
Chapter 12 concludes the research findings and refines all the highlights of the study.
Chapter 13 introduces the research methodology and sources of research data for your understanding.
Years considered for this report:
Historical Years: 2014-2018
Base Year: 2019
Estimated Year: 2019
Forecast Period: 2019-2026
1 Anti-Obesity Therapeutics Market Overview
1.1 Product Overview and Scope of Anti-Obesity Therapeutics
1.2 Anti-Obesity Therapeutics Segment by Type
1.2.1 Global Anti-Obesity Therapeutics Production and CAGR (%) Comparison by Type (2014-2026)
1.2.2 The Market Profile of Centrally Acting Anti-obesity Drugs
1.2.3 The Market Profile of Peripherally Acting Anti-obesity Drugs
1.3 Global Anti-Obesity Therapeutics Segment by Application
1.3.1 Anti-Obesity Therapeutics Consumption (Sales) Comparison by Application (2014-2026)
1.3.2 The Market Profile of Hospital Use
1.3.3 The Market Profile of Clinic Use
1.3.4 The Market Profile of Household
1.3.5 The Market Profile of Other
1.4 Global Anti-Obesity Therapeutics Market by Region (2014-2026)
1.4.1 Global Anti-Obesity Therapeutics Market Size (Value) and CAGR (%) Comparison by Region (2014-2026)
1.4.2 United States Anti-Obesity Therapeutics Market Status and Prospect (2014-2026)
1.4.3 Europe Anti-Obesity Therapeutics Market Status and Prospect (2014-2026)
1.4.3.1 Germany Anti-Obesity Therapeutics Market Status and Prospect (2014-2026)
1.4.3.2 UK Anti-Obesity Therapeutics Market Status and Prospect (2014-2026)
1.4.3.3 France Anti-Obesity Therapeutics Market Status and Prospect (2014-2026)
1.4.3.4 Italy Anti-Obesity Therapeutics Market Status and Prospect (2014-2026)
1.4.3.5 Spain Anti-Obesity Therapeutics Market Status and Prospect (2014-2026)
1.4.3.6 Russia Anti-Obesity Therapeutics Market Status and Prospect (2014-2026)
1.4.3.7 Poland Anti-Obesity Therapeutics Market Status and Prospect (2014-2026)
1.4.4 China Anti-Obesity Therapeutics Market Status and Prospect (2014-2026)
1.4.5 Japan Anti-Obesity Therapeutics Market Status and Prospect (2014-2026)
1.4.6 India Anti-Obesity Therapeutics Market Status and Prospect (2014-2026)
1.4.7 Southeast Asia Anti-Obesity Therapeutics Market Status and Prospect (2014-2026)
1.4.7.1 Malaysia Anti-Obesity Therapeutics Market Status and Prospect (2014-2026)
1.4.7.2 Singapore Anti-Obesity Therapeutics Market Status and Prospect (2014-2026)
1.4.7.3 Philippines Anti-Obesity Therapeutics Market Status and Prospect (2014-2026)
1.4.7.4 Indonesia Anti-Obesity Therapeutics Market Status and Prospect (2014-2026)
1.4.7.5 Thailand Anti-Obesity Therapeutics Market Status and Prospect (2014-2026)
1.4.7.6 Vietnam Anti-Obesity Therapeutics Market Status and Prospect (2014-2026)
1.4.8 Central and South America Anti-Obesity Therapeutics Market Status and Prospect (2014-2026)
1.4.8.1 Brazil Anti-Obesity Therapeutics Market Status and Prospect (2014-2026)
1.4.8.2 Mexico Anti-Obesity Therapeutics Market Status and Prospect (2014-2026)
1.4.8.3 Colombia Anti-Obesity Therapeutics Market Status and Prospect (2014-2026)
1.4.9 Middle East and Africa Anti-Obesity Therapeutics Market Status and Prospect (2014-2026)
1.4.9.1 Saudi Arabia Anti-Obesity Therapeutics Market Status and Prospect (2014-2026)
1.4.9.2 United Arab Emirates Anti-Obesity Therapeutics Market Status and Prospect (2014-2026)
1.4.9.3 Turkey Anti-Obesity Therapeutics Market Status and Prospect (2014-2026)
1.4.9.4 Egypt Anti-Obesity Therapeutics Market Status and Prospect (2014-2026)
1.4.9.5 South Africa Anti-Obesity Therapeutics Market Status and Prospect (2014-2026)
1.4.9.6 Nigeria Anti-Obesity Therapeutics Market Status and Prospect (2014-2026)
1.5 Global Market Size (Value) of Anti-Obesity Therapeutics (2014-2026)
1.5.1 Global Anti-Obesity Therapeutics Revenue Status and Outlook (2014-2026)
1.5.2 Global Anti-Obesity Therapeutics Production Status and Outlook (2014-2026)
2 Global Anti-Obesity Therapeutics Market Landscape by Player
2.1 Global Anti-Obesity Therapeutics Production and Share by Player (2014-2019)
2.2 Global Anti-Obesity Therapeutics Revenue and Market Share by Player (2014-2019)
2.3 Global Anti-Obesity Therapeutics Average Price by Player (2014-2019)
2.4 Anti-Obesity Therapeutics Manufacturing Base Distribution, Sales Area and Product Type by Player
2.5 Anti-Obesity Therapeutics Market Competitive Situation and Trends
2.5.1 Anti-Obesity Therapeutics Market Concentration Rate
2.5.2 Anti-Obesity Therapeutics Market Share of Top 3 and Top 6 Players
2.5.3 Mergers & Acquisitions, Expansion
3 Players Profiles
3.1 Vivus
3.1.1 Vivus Basic Information, Manufacturing Base, Sales Area and Competitors
3.1.2 Anti-Obesity Therapeutics Product Profiles, Application and Specification
3.1.3 Vivus Anti-Obesity Therapeutics Market Performance (2014-2019)
3.1.4 Vivus Business Overview
3.2 Rhythm Pharmaceuticals
3.2.1 Rhythm Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Competitors
3.2.2 Anti-Obesity Therapeutics Product Profiles, Application and Specification
3.2.3 Rhythm Pharmaceuticals Anti-Obesity Therapeutics Market Performance (2014-2019)
3.2.4 Rhythm Pharmaceuticals Business Overview
3.3 Zafgen
3.3.1 Zafgen Basic Information, Manufacturing Base, Sales Area and Competitors
3.3.2 Anti-Obesity Therapeutics Product Profiles, Application and Specification
3.3.3 Zafgen Anti-Obesity Therapeutics Market Performance (2014-2019)
3.3.4 Zafgen Business Overview
3.4 Eisai Company
3.4.1 Eisai Company Basic Information, Manufacturing Base, Sales Area and Competitors
3.4.2 Anti-Obesity Therapeutics Product Profiles, Application and Specification
3.4.3 Eisai Company Anti-Obesity Therapeutics Market Performance (2014-2019)
3.4.4 Eisai Company Business Overview
3.5 Pfizer
3.5.1 Pfizer Basic Information, Manufacturing Base, Sales Area and Competitors
3.5.2 Anti-Obesity Therapeutics Product Profiles, Application and Specification
3.5.3 Pfizer Anti-Obesity Therapeutics Market Performance (2014-2019)
3.5.4 Pfizer Business Overview
3.6 BoehringerIngelheim GmbH
3.6.1 BoehringerIngelheim GmbH Basic Information, Manufacturing Base, Sales Area and Competitors
3.6.2 Anti-Obesity Therapeutics Product Profiles, Application and Specification
3.6.3 BoehringerIngelheim GmbH Anti-Obesity Therapeutics Market Performance (2014-2019)
3.6.4 BoehringerIngelheim GmbH Business Overview
3.7 FlaxoSithKline plc.
3.7.1 FlaxoSithKline plc. Basic Information, Manufacturing Base, Sales Area and Competitors
3.7.2 Anti-Obesity Therapeutics Product Profiles, Application and Specification
3.7.3 FlaxoSithKline plc. Anti-Obesity Therapeutics Market Performance (2014-2019)
3.7.4 FlaxoSithKline plc. Business Overview
3.8 Bristol-Myers Squibb
3.8.1 Bristol-Myers Squibb Basic Information, Manufacturing Base, Sales Area and Competitors
3.8.2 Anti-Obesity Therapeutics Product Profiles, Application and Specification
3.8.3 Bristol-Myers Squibb Anti-Obesity Therapeutics Market Performance (2014-2019)
3.8.4 Bristol-Myers Squibb Business Overview
3.9 Norgine Pharmaceuticals Ltd.
3.9.1 Norgine Pharmaceuticals Ltd. Basic Information, Manufacturing Base, Sales Area and Competitors
3.9.2 Anti-Obesity Therapeutics Product Profiles, Application and Specification
3.9.3 Norgine Pharmaceuticals Ltd. Anti-Obesity Therapeutics Market Performance (2014-2019)
3.9.4 Norgine Pharmaceuticals Ltd. Business Overview
3.10 Alizyme
3.10.1 Alizyme Basic Information, Manufacturing Base, Sales Area and Competitors
3.10.2 Anti-Obesity Therapeutics Product Profiles, Application and Specification
3.10.3 Alizyme Anti-Obesity Therapeutics Market Performance (2014-2019)
3.10.4 Alizyme Business Overview
3.11 Shionogi USA
3.11.1 Shionogi USA Basic Information, Manufacturing Base, Sales Area and Competitors
3.11.2 Anti-Obesity Therapeutics Product Profiles, Application and Specification
3.11.3 Shionogi USA Anti-Obesity Therapeutics Market Performance (2014-2019)
3.11.4 Shionogi USA Business Overview
3.12 Takeda Pharmaceutical
3.12.1 Takeda Pharmaceutical Basic Information, Manufacturing Base, Sales Area and Competitors
3.12.2 Anti-Obesity Therapeutics Product Profiles, Application and Specification
3.12.3 Takeda Pharmaceutical Anti-Obesity Therapeutics Market Performance (2014-2019)
3.12.4 Takeda Pharmaceutical Business Overview
3.13 Novo Nordisk
3.13.1 Novo Nordisk Basic Information, Manufacturing Base, Sales Area and Competitors
3.13.2 Anti-Obesity Therapeutics Product Profiles, Application and Specification
3.13.3 Novo Nordisk Anti-Obesity Therapeutics Market Performance (2014-2019)
3.13.4 Novo Nordisk Business Overview
4 Global Anti-Obesity Therapeutics Production, Revenue (Value), Price Trend by Type
4.1 Global Anti-Obesity Therapeutics Production and Market Share by Type (2014-2019)
4.2 Global Anti-Obesity Therapeutics Revenue and Market Share by Type (2014-2019)
4.3 Global Anti-Obesity Therapeutics Price by Type (2014-2019)
4.4 Global Anti-Obesity Therapeutics Production Growth Rate by Type (2014-2019)
4.4.1 Global Anti-Obesity Therapeutics Production Growth Rate of Centrally Acting Anti-obesity Drugs (2014-2019)
4.4.2 Global Anti-Obesity Therapeutics Production Growth Rate of Peripherally Acting Anti-obesity Drugs (2014-2019)
5 Global Anti-Obesity Therapeutics Market Analysis by Application
5.1 Global Anti-Obesity Therapeutics Consumption and Market Share by Application (2014-2019)
5.2 Global Anti-Obesity Therapeutics Consumption Growth Rate by Application (2014-2019)
5.2.1 Global Anti-Obesity Therapeutics Consumption Growth Rate of Hospital Use (2014-2019)
5.2.2 Global Anti-Obesity Therapeutics Consumption Growth Rate of Clinic Use (2014-2019)
5.2.3 Global Anti-Obesity Therapeutics Consumption Growth Rate of Household (2014-2019)
5.2.4 Global Anti-Obesity Therapeutics Consumption Growth Rate of Other (2014-2019)
6 Global Anti-Obesity Therapeutics Production, Consumption, Export, Import by Region (2014-2019)
6.1 Global Anti-Obesity Therapeutics Consumption by Region (2014-2019)
6.2 United States Anti-Obesity Therapeutics Production, Consumption, Export, Import (2014-2019)
6.3 Europe Anti-Obesity Therapeutics Production, Consumption, Export, Import (2014-2019)
6.4 China Anti-Obesity Therapeutics Production, Consumption, Export, Import (2014-2019)
6.5 Japan Anti-Obesity Therapeutics Production, Consumption, Export, Import (2014-2019)
6.6 India Anti-Obesity Therapeutics Production, Consumption, Export, Import (2014-2019)
6.7 Southeast Asia Anti-Obesity Therapeutics Production, Consumption, Export, Import (2014-2019)
6.8 Central and South America Anti-Obesity Therapeutics Production, Consumption, Export, Import (2014-2019)
6.9 Middle East and Africa Anti-Obesity Therapeutics Production, Consumption, Export, Import (2014-2019)
7 Global Anti-Obesity Therapeutics Production, Revenue (Value) by Region (2014-2019)
7.1 Global Anti-Obesity Therapeutics Production and Market Share by Region (2014-2019)
7.2 Global Anti-Obesity Therapeutics Revenue (Value) and Market Share by Region (2014-2019)
7.3 Global Anti-Obesity Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
7.4 United States Anti-Obesity Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
7.5 Europe Anti-Obesity Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
7.6 China Anti-Obesity Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
7.7 Japan Anti-Obesity Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
7.8 India Anti-Obesity Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
7.9 Southeast Asia Anti-Obesity Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
7.10 Central and South America Anti-Obesity Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
7.11 Middle East and Africa Anti-Obesity Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
8 Anti-Obesity Therapeutics Manufacturing Analysis
8.1 Anti-Obesity Therapeutics Key Raw Materials Analysis
8.1.1 Key Raw Materials Introduction
8.1.2 Price Trend of Key Raw Materials
8.1.3 Key Suppliers of Raw Materials
8.1.4 Market Concentration Rate of Raw Materials
8.2 Manufacturing Cost Analysis
8.2.1 Labor Cost Analysis
8.2.2 Manufacturing Cost Structure Analysis
8.3 Manufacturing Process Analysis of Anti-Obesity Therapeutics
9 Industrial Chain, Sourcing Strategy and Downstream Buyers
9.1 Anti-Obesity Therapeutics Industrial Chain Analysis
9.2 Raw Materials Sources of Anti-Obesity Therapeutics Major Players in 2018
9.3 Downstream Buyers
10 Market Dynamics
10.1 Drivers
10.2 Restraints
10.3 Opportunities
10.3.1 Advances in Innovation and Technology for Anti-Obesity Therapeutics
10.3.2 Increased Demand in Emerging Markets
10.4 Challenges
10.4.1 The Performance of Alternative Product Type is Getting Better and Better
10.4.2 Price Variance Caused by Fluctuations in Raw Material Prices
10.5 Porter’s Five Forces Analysis
10.5.1 Threat of New Entrants
10.5.2 Threat of Substitutes
10.5.3 Bargaining Power of Suppliers
10.5.4 Bargaining Power of Buyers
10.5.5 Intensity of Competitive Rivalry
11 Global Anti-Obesity Therapeutics Market Forecast (2019-2026)
11.1 Global Anti-Obesity Therapeutics Production, Revenue Forecast (2019-2026)
11.1.1 Global Anti-Obesity Therapeutics Production and Growth Rate Forecast (2019-2026)
11.1.2 Global Anti-Obesity Therapeutics Revenue and Growth Rate Forecast (2019-2026)
11.1.3 Global Anti-Obesity Therapeutics Price and Trend Forecast (2019-2026)
11.2 Global Anti-Obesity Therapeutics Production, Consumption, Export and Import Forecast by Region (2019-2026)
11.2.1 United States Anti-Obesity Therapeutics Production, Consumption, Export and Import Forecast (2019-2026)
11.2.2 Europe Anti-Obesity Therapeutics Production, Consumption, Export and Import Forecast (2019-2026)
11.2.3 China Anti-Obesity Therapeutics Production, Consumption, Export and Import Forecast (2019-2026)
11.2.4 Japan Anti-Obesity Therapeutics Production, Consumption, Export and Import Forecast (2019-2026)
11.2.5 India Anti-Obesity Therapeutics Production, Consumption, Export and Import Forecast (2019-2026)
11.2.6 Southeast Asia Anti-Obesity Therapeutics Production, Consumption, Export and Import Forecast (2019-2026)
11.2.7 Central and South America Anti-Obesity Therapeutics Production, Consumption, Export and Import Forecast (2019-2026)
11.2.8 Middle East and Africa Anti-Obesity Therapeutics Production, Consumption, Export and Import Forecast (2019-2026)
11.3 Global Anti-Obesity Therapeutics Production, Revenue and Price Forecast by Type (2019-2026)
11.4 Global Anti-Obesity Therapeutics Consumption Forecast by Application (2019-2026)
12 Research Findings and Conclusion
13 Appendix
13.1 Methodology
13.2 Research Data Source
List of Tables and Figures
Figure Anti-Obesity Therapeutics Product Picture
Table Global Anti-Obesity Therapeutics Production and CAGR (%) Comparison by Type
Table Profile of Centrally Acting Anti-obesity Drugs
Table Profile of Peripherally Acting Anti-obesity Drugs
Table Anti-Obesity Therapeutics Consumption (Sales) Comparison by Application (2014-2026)
Table Profile of Hospital Use
Table Profile of Clinic Use
Table Profile of Household
Table Profile of Other
Figure Global Anti-Obesity Therapeutics Market Size (Value) and CAGR (%) (2014-2026)
Figure United States Anti-Obesity Therapeutics Revenue and Growth Rate (2014-2026)
Figure Europe Anti-Obesity Therapeutics Revenue and Growth Rate (2014-2026)
Figure Germany Anti-Obesity Therapeutics Revenue and Growth Rate (2014-2026)
Figure UK Anti-Obesity Therapeutics Revenue and Growth Rate (2014-2026)
Figure France Anti-Obesity Therapeutics Revenue and Growth Rate (2014-2026)
Figure Italy Anti-Obesity Therapeutics Revenue and Growth Rate (2014-2026)
Figure Spain Anti-Obesity Therapeutics Revenue and Growth Rate (2014-2026)
Figure Russia Anti-Obesity Therapeutics Revenue and Growth Rate (2014-2026)
Figure Poland Anti-Obesity Therapeutics Revenue and Growth Rate (2014-2026)
Figure China Anti-Obesity Therapeutics Revenue and Growth Rate (2014-2026)
Figure Japan Anti-Obesity Therapeutics Revenue and Growth Rate (2014-2026)
Figure India Anti-Obesity Therapeutics Revenue and Growth Rate (2014-2026)
Figure Southeast Asia Anti-Obesity Therapeutics Revenue and Growth Rate (2014-2026)
Figure Malaysia Anti-Obesity Therapeutics Revenue and Growth Rate (2014-2026)
Figure Singapore Anti-Obesity Therapeutics Revenue and Growth Rate (2014-2026)
Figure Philippines Anti-Obesity Therapeutics Revenue and Growth Rate (2014-2026)
Figure Indonesia Anti-Obesity Therapeutics Revenue and Growth Rate (2014-2026)
Figure Thailand Anti-Obesity Therapeutics Revenue and Growth Rate (2014-2026)
Figure Vietnam Anti-Obesity Therapeutics Revenue and Growth Rate (2014-2026)
Figure Central and South America Anti-Obesity Therapeutics Revenue and Growth Rate (2014-2026)
Figure Brazil Anti-Obesity Therapeutics Revenue and Growth Rate (2014-2026)
Figure Mexico Anti-Obesity Therapeutics Revenue and Growth Rate (2014-2026)
Figure Colombia Anti-Obesity Therapeutics Revenue and Growth Rate (2014-2026)
Figure Middle East and Africa Anti-Obesity Therapeutics Revenue and Growth Rate (2014-2026)
Figure Saudi Arabia Anti-Obesity Therapeutics Revenue and Growth Rate (2014-2026)
Figure United Arab Emirates Anti-Obesity Therapeutics Revenue and Growth Rate (2014-2026)
Figure Turkey Anti-Obesity Therapeutics Revenue and Growth Rate (2014-2026)
Figure Egypt Anti-Obesity Therapeutics Revenue and Growth Rate (2014-2026)
Figure South Africa Anti-Obesity Therapeutics Revenue and Growth Rate (2014-2026)
Figure Nigeria Anti-Obesity Therapeutics Revenue and Growth Rate (2014-2026)
Figure Global Anti-Obesity Therapeutics Production Status and Outlook (2014-2026)
Table Global Anti-Obesity Therapeutics Production by Player (2014-2019)
Table Global Anti-Obesity Therapeutics Production Share by Player (2014-2019)
Figure Global Anti-Obesity Therapeutics Production Share by Player in 2018
Table Anti-Obesity Therapeutics Revenue by Player (2014-2019)
Table Anti-Obesity Therapeutics Revenue Market Share by Player (2014-2019)
Table Anti-Obesity Therapeutics Price by Player (2014-2019)
Table Anti-Obesity Therapeutics Manufacturing Base Distribution and Sales Area by Player
Table Anti-Obesity Therapeutics Product Type by Player
Table Mergers & Acquisitions, Expansion Plans
Table Vivus Profile
Table Vivus Anti-Obesity Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
Table Rhythm Pharmaceuticals Profile
Table Rhythm Pharmaceuticals Anti-Obesity Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
Table Zafgen Profile
Table Zafgen Anti-Obesity Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
Table Eisai Company Profile
Table Eisai Company Anti-Obesity Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
Table Pfizer Profile
Table Pfizer Anti-Obesity Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
Table BoehringerIngelheim GmbH Profile
Table BoehringerIngelheim GmbH Anti-Obesity Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
Table FlaxoSithKline plc. Profile
Table FlaxoSithKline plc. Anti-Obesity Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
Table Bristol-Myers Squibb Profile
Table Bristol-Myers Squibb Anti-Obesity Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
Table Norgine Pharmaceuticals Ltd. Profile
Table Norgine Pharmaceuticals Ltd. Anti-Obesity Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
Table Alizyme Profile
Table Alizyme Anti-Obesity Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
Table Shionogi USA Profile
Table Shionogi USA Anti-Obesity Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
Table Takeda Pharmaceutical Profile
Table Takeda Pharmaceutical Anti-Obesity Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
Table Novo Nordisk Profile
Table Novo Nordisk Anti-Obesity Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
Table Global Anti-Obesity Therapeutics Production by Type (2014-2019)
Table Global Anti-Obesity Therapeutics Production Market Share by Type (2014-2019)
Figure Global Anti-Obesity Therapeutics Production Market Share by Type in 2018
Table Global Anti-Obesity Therapeutics Revenue by Type (2014-2019)
Table Global Anti-Obesity Therapeutics Revenue Market Share by Type (2014-2019)
Figure Global Anti-Obesity Therapeutics Revenue Market Share by Type in 2018
Table Anti-Obesity Therapeutics Price by Type (2014-2019)
Figure Global Anti-Obesity Therapeutics Production Growth Rate of Centrally Acting Anti-obesity Drugs (2014-2019)
Figure Global Anti-Obesity Therapeutics Production Growth Rate of Peripherally Acting Anti-obesity Drugs (2014-2019)
Table Global Anti-Obesity Therapeutics Consumption by Application (2014-2019)
Table Global Anti-Obesity Therapeutics Consumption Market Share by Application (2014-2019)
Table Global Anti-Obesity Therapeutics Consumption of Hospital Use (2014-2019)
Table Global Anti-Obesity Therapeutics Consumption of Clinic Use (2014-2019)
Table Global Anti-Obesity Therapeutics Consumption of Household (2014-2019)
Table Global Anti-Obesity Therapeutics Consumption of Other (2014-2019)
Table Global Anti-Obesity Therapeutics Consumption by Region (2014-2019)
Table Global Anti-Obesity Therapeutics Consumption Market Share by Region (2014-2019)
Table United States Anti-Obesity Therapeutics Production, Consumption, Export, Import (2014-2019)
Table Europe Anti-Obesity Therapeutics Production, Consumption, Export, Import (2014-2019)
Table China Anti-Obesity Therapeutics Production, Consumption, Export, Import (2014-2019)
Table Japan Anti-Obesity Therapeutics Production, Consumption, Export, Import (2014-2019)
Table India Anti-Obesity Therapeutics Production, Consumption, Export, Import (2014-2019)
Table Southeast Asia Anti-Obesity Therapeutics Production, Consumption, Export, Import (2014-2019)
Table Central and South America Anti-Obesity Therapeutics Production, Consumption, Export, Import (2014-2019)
Table Middle East and Africa Anti-Obesity Therapeutics Production, Consumption, Export, Import (2014-2019)
Table Global Anti-Obesity Therapeutics Production by Region (2014-2019)
Table Global Anti-Obesity Therapeutics Production Market Share by Region (2014-2019)
Figure Global Anti-Obesity Therapeutics Production Market Share by Region (2014-2019)
Figure Global Anti-Obesity Therapeutics Production Market Share by Region in 2018
Table Global Anti-Obesity Therapeutics Revenue by Region (2014-2019)
Table Global Anti-Obesity Therapeutics Revenue Market Share by Region (2014-2019)
Figure Global Anti-Obesity Therapeutics Revenue Market Share by Region (2014-2019)
Figure Global Anti-Obesity Therapeutics Revenue Market Share by Region in 2018
Table Global Anti-Obesity Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
Table United States Anti-Obesity Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
Table Europe Anti-Obesity Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
Table China Anti-Obesity Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
Table Japan Anti-Obesity Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
Table India Anti-Obesity Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
Table Southeast Asia Anti-Obesity Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
Table Central and South America Anti-Obesity Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
Table Middle East and Africa Anti-Obesity Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
Table Key Raw Materials Introduction of Anti-Obesity Therapeutics
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Market Concentration Rate of Raw Materials
Figure Manufacturing Cost Structure Analysis
Figure Manufacturing Process Analysis of Anti-Obesity Therapeutics
Figure Anti-Obesity Therapeutics Industrial Chain Analysis
Table Raw Materials Sources of Anti-Obesity Therapeutics Major Players in 2018
Table Downstream Buyers
Figure Global Anti-Obesity Therapeutics Production and Growth Rate Forecast (2019-2026)
Figure Global Anti-Obesity Therapeutics Revenue and Growth Rate Forecast (2019-2026)
Figure Global Anti-Obesity Therapeutics Price and Trend Forecast (2019-2026)
Table United States Anti-Obesity Therapeutics Production, Consumption, Export and Import Forecast (2019-2026)
Table Europe Anti-Obesity Therapeutics Production, Consumption, Export and Import Forecast (2019-2026)
Table China Anti-Obesity Therapeutics Production, Consumption, Export and Import Forecast (2019-2026)
Table Japan Anti-Obesity Therapeutics Production, Consumption, Export and Import Forecast (2019-2026)
Table India Anti-Obesity Therapeutics Production, Consumption, Export and Import Forecast (2019-2026)
Table Southeast Asia Anti-Obesity Therapeutics Production, Consumption, Export and Import Forecast (2019-2026)
Table Southeast Asia Anti-Obesity Therapeutics Production, Consumption, Export and Import Forecast (2019-2026)
Table Middle East and Africa Anti-Obesity Therapeutics Production, Consumption, Export and Import Forecast (2019-2026)
Table Global Anti-Obesity Therapeutics Market Production Forecast, by Type
Table Global Anti-Obesity Therapeutics Production Volume Market Share Forecast, by Type
Table Global Anti-Obesity Therapeutics Market Revenue Forecast, by Type
Table Global Anti-Obesity Therapeutics Revenue Market Share Forecast, by Type
Table Global Anti-Obesity Therapeutics Price Forecast, by Type
Table Global Anti-Obesity Therapeutics Market Production Forecast, by Application
Table Global Anti-Obesity Therapeutics Production Volume Market Share Forecast, by Application
Table Global Anti-Obesity Therapeutics Market Revenue Forecast, by Application
Table Global Anti-Obesity Therapeutics Revenue Market Share Forecast, by Application
Table Global Anti-Obesity Therapeutics Price Forecast, by Application
Similar Reports
Online banking or internet banking is a service provided by retail bank, virtual bank (neo banks) or credit unions. Online banking provides the customers with a secure website through which they can conduct financial transactions. Recent trends show that, customers are keenly adopting on...
- Publish Date: July 31, 2017
- $5370
ATMs have evolved from just cash dispensing machines to multifunctional equipment that provide not only cash withdrawal facilities but offer currency conversions facilities, account information, deposits, transfers, bill payment, cash recycling among other services. The Asia-Pacific region is becoming increasingly characterized by technology-facilitated transactions. ...
- Publish Date: March 1, 2016
- $3390
The Global P2P Industry 2016 Deep Market Research Report is a professional and in-depth study on the current state of the P2P industry. The report provides a basic overview of the industry including definitions and classifications. The P2P market analysis is provided for the international markets including development trends, competitive landscape analysis, and key regions development status. ...
- Publish Date: January 15, 2016
- $2800
